-
These models are technology platforms that facilitate drug discovery and fundamental research. Our research is funded by Australian Research Council. This project aims to develop bio-microfluidic
-
This is an exciting opportunity to examine how in this new pandemic world, healthcare as we know it will and must continue to innovate and adapt, leveraging digital health innovations to its full
-
. Around the world, the consumption of products based on plant protein is increasing. However, the extraction and purification of plant proteins create large quantities of waste. This project will
-
conjunction with the ARC Centre of Excellence for Quantum Computation and Communication Technology (CQC2T), is looking for an exceptionally high-performing student to perform advanced theoretical work in
-
immune responses to promote T cell-mediated tumour clearance. Methods: The laboratory uses world-class big-data omics analysis of blood immune cells, including RNAseq, epigenetics, multicolour
-
biologists, and clinicians. Experience in tissue culture. The Cancer, Ageing and Vaccines Laboratory seeks to understand cancer biology and immune responses and to translate these findings into real-world
-
uses world-class big-data omics analysis of immune cells, including RNAseq, genome-wide epigenetics, multicolour flowcytometry, cell sorting, multiplex cytokine analysis, as well as classical
-
in which we will map, as a world first, how innate immunity and innate training differs in humans based on age and sex, and how this affects responses to vaccines. We will be studying these aspects
-
and correlates will differ between younger adults and the elderly, and females compared to males. Methods: The laboratory uses world-class big-data ‘omics’ analysis of blood immune cells, including
-
as well, resulting in increased survival. Methods: The laboratory uses world-class big-data omics analysis of blood immune cells, including RNAseq, epigenetics, multicolour flowcytometry (up to 27